Abstract
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 735-752 |
Number of pages | 18 |
Journal | Pancreas |
Volume | 39 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2010 |
Research programs
- EMC MM-01-39-01